A genome-wide association study of Dupuytren's disease reveals 17 additional variants implicated in fibrosis

A genome-wide association study of Dupuytren's disease reveals 17 additional variants implicated in fibrosis

Individuals with Dupuytren’s disease (DD) are commonly seen by physicians and surgeons across multiple specialties. It is an increasingly common and disabling fibroproliferative disorder of the palmar fascia, which leads to flexion contractures of the digits, and is associated with other tissue spec...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Ng, M, Thakkar, D, Southam, L, Werker, P, Ophoff, R, Becker, K, Nothnagel, M, Franke, A, Nurnberg, P, Espirito-Santo, A, Izadi, D, Hennies, H, Nanchahal, J, Zeggini, E, Furniss, D
Formáid:	Journal article
Foilsithe / Cruthaithe:	Cell Press 2017

Míreanna comhchosúla

Wnt signaling and Dupuytren's disease.
de réir: Dolmans, G, et al.
Foilsithe / Cruthaithe: (2011)

Genome-wide association scan of Dupuytren's disease.
de réir: Furniss, D, et al.
Foilsithe / Cruthaithe: (2011)

A genome-wide association meta-analysis implicates Hedgehog and Notch signaling in Dupuytren’s disease
de réir: Sophie A. Riesmeijer, et al.
Foilsithe / Cruthaithe: (2024-01-01)

Tonometry as an outcome measure for the treatment of Dupuytren’s disease.
de réir: Ball, C, et al.
Foilsithe / Cruthaithe: (2015)

Tonometry as an outcome measure for the treatment of Dupuytren’s disease.
de réir: Ball, C, et al.
Foilsithe / Cruthaithe: (2016)

Meta-Analysis of Genome-Wide Association Studies and Network Analysis-Based Integration with Gene Expression Data Identify New Suggestive Loci and Unravel a Wnt-Centric Network Associated with Dupuytren's Disease.
de réir: Kerstin Becker, et al.
Foilsithe / Cruthaithe: (2016-01-01)

Unraveling the signaling pathways promoting fibrosis in Dupuytren's disease reveals TNF as a therapeutic target.
de réir: Verjee, L, et al.
Foilsithe / Cruthaithe: (2013)

Unravelling the signalling pathways promoting fibrosis in dupuytren's disease reveals TNF as a therapeutic target
de réir: Verjee, L, et al.
Foilsithe / Cruthaithe: (2014)

A systematic review of non-surgical treatments for early Dupuytren’s disease
de réir: Ball, C, et al.
Foilsithe / Cruthaithe: (2015)

A weighted genetic risk score predicts surgical recurrence independent of high-risk clinical features in Dupuytren’s disease
de réir: Riesmeijer, S, et al.
Foilsithe / Cruthaithe: (2019)

Systematic review of non-surgical treatments for early Dupuytren’s disease
de réir: Ball, C, et al.
Foilsithe / Cruthaithe: (2016)

Treatment for Dupuytren's disease
de réir: Nanchahal, J, et al.
Foilsithe / Cruthaithe: (2013)

Recent advances in the understanding of Dupuytren's disease
de réir: Nanchahal, J, et al.
Foilsithe / Cruthaithe: (2019)

Isometric contraction of Dupuytren's myofibroblasts is inhibited by blocking intercellular junctions.
de réir: Verhoekx, J, et al.
Foilsithe / Cruthaithe: (2013)

Isometric contraction of dupuytren's myofibroblasts is inhibited by blocking intercellular junctions
de réir: Verhoekx, J, et al.
Foilsithe / Cruthaithe: (2013)

Sibling recurrence risk in Dupuytren's disease.
de réir: Capstick, R, et al.
Foilsithe / Cruthaithe: (2013)

Is Dupuytren’s disease really a “disease of the Vikings”?
de réir: Ng, M, et al.
Foilsithe / Cruthaithe: (2019)

Integrative analysis of Dupuytren's disease identifies novel risk locus and reveals a shared genetic etiology with BMI
de réir: Major, M, et al.
Foilsithe / Cruthaithe: (2019)

Myofibroblast distribution in Dupuytren's cords: correlation with digital contracture.
de réir: Verjee, L, et al.
Foilsithe / Cruthaithe: (2009)

Treatments for early-stage Dupuytren’s disease: an evidence-based approach
de réir: Nanchahal, J, et al.
Foilsithe / Cruthaithe: (2023)

Dupuytren's disease: a localised and accessible human fibrotic disorder
de réir: Layton, TB, et al.
Foilsithe / Cruthaithe: (2022)

Imaging for Dupuytren disease: a systematic review of the literature
de réir: Sanne Molenkamp, et al.
Foilsithe / Cruthaithe: (2019-05-01)

Commentary on Larson et al. Genetic and environmental influences in Dupuytren's disease: A study of 30,330 Danish twin pairs
de réir: Furniss, D
Foilsithe / Cruthaithe: (2015)

Predicting the outcome of surgery for the proximal interphalangeal joint in Dupuytren's disease.
de réir: Misra, A, et al.
Foilsithe / Cruthaithe: (2007)

Anti-tumour necrosis factor therapy for early-stage Dupuytren's disease (RIDD): a phase 2b, randomised, double-blind, placebo-controlled trial
de réir: Nanchahal, J, et al.
Foilsithe / Cruthaithe: (2022)

Post-transcriptional regulation of alpha-smooth muscle actin determines the contractile phenotype of Dupuytren's nodular cells.
de réir: Verjee, L, et al.
Foilsithe / Cruthaithe: (2010)

Dupuytren disease: prevalence, incidence, and lifetime risk of surgical intervention. A population-based cohort analysis
de réir: Broekstra, DC, et al.
Foilsithe / Cruthaithe: (2022)

The relationship between body mass index and the risk of development of Dupuytren's disease: a Mendelian randomization study.
de réir: Majeed, M, et al.
Foilsithe / Cruthaithe: (2020)

Adiponectin inhibits fibrosis of the palmar aponeurosis in Dupuytren’s contracture in male patients
de réir: Yoshiaki Yamanaka, et al.
Foilsithe / Cruthaithe: (2023-08-01)

Surgery for Dupuytren's contracture of the fingers.
de réir: Rodrigues, J, et al.
Foilsithe / Cruthaithe: (2015)

What do we know about managing Dupuytren’s Disease cost-effectively?
de réir: Dritsaki, M, et al.
Foilsithe / Cruthaithe: (2018)

What do we know about managing Dupuytren’s disease cost-effectively?
de réir: Melina Dritsaki, et al.
Foilsithe / Cruthaithe: (2018-01-01)

Guillaume Dupuytren
de réir: Romina A Parquet
Foilsithe / Cruthaithe: (2013-01-01)

Dupuytren’s disease
de réir: Richard Trèves
Foilsithe / Cruthaithe: (2011-09-01)

Dupuytren's disease
de réir: Rames Mattar Junior
Foilsithe / Cruthaithe: (2008-03-01)

Optimal functional outcome measures for assessing treatment for Dupuytren's disease: a systematic review and recommendations for future practice.
de réir: Ball, C, et al.
Foilsithe / Cruthaithe: (2013)

The Rationale for Treating the Nodule in Dupuytren’s Disease
de réir: Lynn D. Ketchum, MD
Foilsithe / Cruthaithe: (2014-12-01)

Economic evaluation plan of a randomised controlled trial of intra-nodular injection of anti-TNF and placebo among patients with early Dupuytren’s disease: Repurposing Anti-TNF for Treating Dupuytren’s Disease (RIDD)
de réir: Png, M, et al.
Foilsithe / Cruthaithe: (2019)

Dupuytren’s disease predicts increased all-cause and cancer-specific mortality: analysis of a large cohort from the UK Clinical Practice Research Datalink
de réir: Kuo, R, et al.
Foilsithe / Cruthaithe: (2019)

Paediatric Dupuytren's disease
de réir: Pradeoth Mukundan Korambayil, et al.
Foilsithe / Cruthaithe: (2011-09-01)